Sareum (LON:SAR) Share Price Crosses Below 200 Day Moving Average – Time to Sell?

Shares of Sareum Holdings plc (LON:SAR) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 29.92 ($0.38) and traded as low as GBX 26.56 ($0.33). Sareum shares last traded at GBX 26.65 ($0.33), with a volume of 25,737 shares trading hands.

Sareum Stock Performance

The company has a fifty day moving average of GBX 26.09 and a two-hundred day moving average of GBX 29.70. The company has a market cap of £28.77 million, a PE ratio of -444.17 and a beta of -1.08.

Sareum Company Profile

Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases.